217 related articles for article (PubMed ID: 21553280)
1. Standard or extended-duration prophylaxis in medical patients? A review of the evidence.
Stark JE; Smith WJ
J Thromb Thrombolysis; 2011 Oct; 32(3):318-27. PubMed ID: 21553280
[TBL] [Abstract][Full Text] [Related]
2. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
[TBL] [Abstract][Full Text] [Related]
3. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
[TBL] [Abstract][Full Text] [Related]
4. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Turpie AG; Wildgoose P; Yusen RD
J Thromb Thrombolysis; 2006 Aug; 22(1):31-8. PubMed ID: 16786230
[TBL] [Abstract][Full Text] [Related]
5. Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial.
Yusen RD; Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Chen M; Deslandes B; Turpie AG
Thromb Haemost; 2013 Dec; 110(6):1152-63. PubMed ID: 24085227
[TBL] [Abstract][Full Text] [Related]
6. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
7. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
[TBL] [Abstract][Full Text] [Related]
8. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.
Dentali F; Mumoli N; Prisco D; Fontanella A; Di Minno MN
Thromb Haemost; 2017 Feb; 117(3):606-617. PubMed ID: 28078350
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
[TBL] [Abstract][Full Text] [Related]
11. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Gibson CM; Halaby R; Korjian S; Daaboul Y; Arbetter DF; Yee MK; Goldhaber SZ; Hull R; Hernandez AF; Lu SP; Bandman O; Leeds JM; Gold A; Harrington RA; Cohen AT;
Am Heart J; 2017 Mar; 185():93-100. PubMed ID: 28267480
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study.
Turpie AG; Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Chen M; Yusen RD;
Stroke; 2013 Jan; 44(1):249-51. PubMed ID: 23117723
[TBL] [Abstract][Full Text] [Related]
14. Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials.
Liew AY; Piran S; Eikelboom JW; Douketis JD
J Thromb Thrombolysis; 2017 Apr; 43(3):291-301. PubMed ID: 27900627
[TBL] [Abstract][Full Text] [Related]
15. Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.
Albertsen IE; Larsen TB; Rasmussen LH; Overvad TF; Lip GY
Drugs; 2012 Sep; 72(13):1755-64. PubMed ID: 22876779
[TBL] [Abstract][Full Text] [Related]
16. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
Chi G; Gibson CM; Kalayci A; Cohen AT; Hernandez AF; Hull RD; Kahe F; Jafarizade M; Sharfaei S; Liu Y; Harrington RA; Goldhaber SZ
Intensive Care Med; 2019 Apr; 45(4):477-487. PubMed ID: 30778649
[TBL] [Abstract][Full Text] [Related]
17. Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol.
Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos A; Tapson V
J Thromb Thrombolysis; 2011 May; 31(4):407-16. PubMed ID: 21359646
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
20. Thromboprophylaxis in nonsurgical patients.
Streiff MB; Lau BD
Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
